+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Bevacizumab - Biosimilars Insight, 2020 - Product Thumbnail Image

Bevacizumab - Biosimilars Insight, 2020

  • Report
  • August 2020
  • 125 pages
From
Remicade (Infliximab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • October 2016
  • 50 Pages
From
Adalimumab - Biosimilar Insight, 2021 - Product Thumbnail Image

Adalimumab - Biosimilar Insight, 2021

  • Drug Pipelines
  • May 2021
  • 120 Pages
From
Infliximab - Biosimilars Insight, 2020 - Product Thumbnail Image

Infliximab - Biosimilars Insight, 2020

  • Report
  • August 2020
  • 90 pages
From
Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • October 2016
  • 80 Pages
From
Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019

  • Report
  • September 2019
  • 28 pages
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • October 2016
  • 85 Pages
From
From
From
Loading Indicator
adroll